Department of Orthopaedics, Qilu Hospital of Shandong University, Shandong University Centre for Orthopaedics, Advanced Medical Research Institute, Shandong University, No. 107 Wenhua West Road, Lixia District, Jinan, 250012, China.
Department of Orthopedics, Tianjin Medical University General Hospital, International Science and Technology Cooperation Base of Spinal Cord Injury, Tianjin Key Laboratory of Spine and Spinal Cord Injury, No. 154 Anshan Road, Heping District, Tianjin, 300052, China.
Adv Sci (Weinh). 2024 Jun;11(21):e2308993. doi: 10.1002/advs.202308993. Epub 2024 Mar 22.
Neural stem cells (NSCs) transplantation is an attractive and promising treatment strategy for spinal cord injury (SCI). Various pathological processes including the severe inflammatory cascade and difficulty in stable proliferation and differentiation of NSCs limit its application and translation. Here, a novel physico-chemical bifunctional neural stem cells delivery system containing magnetic nanoparticles (MNPs and methylprednisolone (MP) is designed to repair SCI, the former regulates NSCs differentiation through magnetic mechanical stimulation in the chronic phase, while the latter alleviates inflammatory response in the acute phase. The delivery system releases MP to promote microglial M2 polarization, inhibit M1 polarization, and reduce neuronal apoptosis. Meanwhile, NSCs tend to differentiate into functional neurons with magnetic mechanical stimulation generated by MNPs in the static magnetic field, which is related to the activation of the PI3K/AKT/mTOR pathway. SCI mice achieve better functional recovery after receiving NSCs transplantation via physico-chemical bifunctional delivery system, which has milder inflammation, higher number of M2 microglia, more functional neurons, and axonal regeneration. Together, this bifunctional NSCs delivery system combined physical mechanical stimulation and chemical drug therapy is demonstrated to be effective, which provides new treatment insights into clinical transformation of SCI repair.
神经干细胞(NSCs)移植是一种有吸引力和有前途的脊髓损伤(SCI)治疗策略。各种病理过程,包括严重的炎症级联反应和 NSCs 的稳定增殖和分化困难,限制了其应用和转化。在这里,设计了一种新型物理化学双功能神经干细胞递药系统,包含磁性纳米颗粒(MNPs)和甲基强的松龙(MP),用于修复 SCI,前者通过慢性期的磁力学刺激调节 NSCs 分化,而后者则减轻急性期的炎症反应。递药系统释放 MP 以促进小胶质细胞 M2 极化,抑制 M1 极化,并减少神经元凋亡。同时,在静磁场中由 MNPs 产生的磁力学刺激促使 NSCs 向功能性神经元分化,这与 PI3K/AKT/mTOR 通路的激活有关。接受物理化学双功能递药系统的 NSCs 移植后,SCI 小鼠实现了更好的功能恢复,炎症更轻,M2 小胶质细胞数量更多,功能性神经元更多,轴突再生更好。总之,这种双功能 NSCs 递药系统结合了物理机械刺激和化学药物治疗,被证明是有效的,为 SCI 修复的临床转化提供了新的治疗思路。